insights_auto
Parashikimi: 54.9% optimist·5.6% pesimist
Shko tek analizachevron_right
AMGN:NASDAQ
Amgen Inc
465,67 US$
arrow_downward
-0,30%(-1,39) 1D
465,81 US$
arrow_upward
+0,03% (+0,14)bedtimeJashtë orarit
Mbyllur: 13 nën, 4:00:01 m.d., GMT-5 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për AMGN...
Hap
467,53 US$
I lartë
468,00 US$
I ulët
462,22 US$
Kapitalizimi i tregut
251,89 mld
Vëllimi mesatar
2,73 mln
Vëllimi
1,48 mln
Dividendi
2,16%
Dividendi tremujor
2,52 US$
Data e ndërprerjes së dividendit
20 nën 2026
Raporti çmim/fitim
27,00
Maksimumi 52-javor
483,99 US$
Minimumi 52-javor
312,53 US$
Fitimet për aksion
17,25 US$
Beta
0,43
Aksionet në qarkullim
540,91 mln
Numri i punonjësve
32 mijë
Hap
467,53 US$
I lartë
468,00 US$
I ulët
462,22 US$
Kapitalizimi i tregut
251,89 mld
Vëllimi mesatar
2,73 mln
Vëllimi
1,48 mln
Dividendi
2,16%
Dividendi tremujor
2,52 US$
Data e ndërprerjes së dividendit
20 nën 2026
Raporti çmim/fitim
27,00
Maksimumi 52-javor
483,99 US$
Minimumi 52-javor
312,53 US$
Fitimet për aksion
17,25 US$
Beta
0,43
Aksionet në qarkullim
540,91 mln
Numri i punonjësve
32 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
CryptoDaily
·
15 orë më parë
"Amgen Inc tokenized stock (xStock)" price data
Trefis
·
1 ditë më parë
Is Amgen Stock Priced Right Against Its Peers?
Yahoo Finance
·
1 ditë më parë
45 ETFs Add to Amgen (AMGN) Holdings on Tuesday
Investor's Business Daily
·
2 ditë më parë
How Amgen, In A Buy Zone, Is Taking On Novartis With A First-Ever
Profili
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Rreth Amgen Inc
Drejtori ekzekutivRobert A. Bradway
Punonjësit31,5 mijë
Themeluar më1980
SeliaThousand Oaks, Kalifornia, Shtetet e Bashkuara të Amerikës
SektoriHealth Care
Industria-
Uebsajtiamgen.com